Medication Treatments for Moderate to Severe Chronic Hand Eczema (CHE)
For moderate to severe chronic hand eczema, topical corticosteroids are first-line therapy, followed by systemic treatments including alitretinoin, immunosuppressants, or retinoids when topical treatments fail. When selecting treatments, consider the severity, chronicity, and previous treatment responses.
First-Line Treatments
Topical Corticosteroids
- Moderate to high-potency topical corticosteroids:
Maintenance Therapy with Topical Corticosteroids
- After achieving control, transition to maintenance therapy:
- Always combine with regular moisturizers, especially after hand washing 1
Topical Calcineurin Inhibitors
- Tacrolimus 0.1% ointment for steroid-sparing in chronic cases 1
- Particularly useful for sensitive areas prone to steroid atrophy
Second-Line Treatments
When topical treatments fail to provide adequate control after 4-8 weeks:
Phototherapy
- PUVA (Psoralen plus UVA) has shown superior efficacy to UVB in hand eczema 2
- Oral PUVA: 81-86% improvement or clearance in hand eczema 2
- Topical PUVA: 58-81% improvement in dyshidrotic eczema 2
Systemic Corticosteroids
- Short-term oral systemic steroids for severe flares 2, 1
- Not recommended for long-term maintenance due to side effects 2
- Can be used to bridge to other systemic therapies 2
Third-Line Treatments
For refractory cases not responding to first and second-line treatments:
Systemic Retinoids
- Oral alitretinoin (10-30mg daily) for chronic cases 1
- Particularly effective for hyperkeratotic hand eczema 3
Immunosuppressants
- Cyclosporine: Effective for steroid-resistant chronic hand dermatitis 2
- Azathioprine: Used for steroid-resistant chronic hand dermatitis 2
- Methotrexate: Used off-label for chronic cases 3, 4
Emerging Therapies
- JAK inhibitors (topical and systemic): Currently under investigation 3
- Dupilumab: May be effective for atopic hand eczema 1, 4
Treatment Algorithm Based on Severity
Moderate CHE:
- Start with moderate-potency topical corticosteroids (mometasone furoate) twice daily for 2-3 weeks
- If inadequate response, increase to high-potency corticosteroids (clobetasol)
- If still inadequate after 4-8 weeks, consider PUVA therapy
- For persistent cases, consider systemic therapy with alitretinoin
Severe CHE:
- Start with high-potency topical corticosteroids (clobetasol) twice daily
- Consider short course of systemic corticosteroids for rapid control
- Initiate PUVA therapy or systemic therapy (alitretinoin, cyclosporine)
- For refractory cases, consider combination therapy or emerging treatments
Important Considerations
- Monitor for side effects: Watch for skin atrophy, cracks/fissures with topical corticosteroids 1
- Treat complications: For fissures, consider propylene glycol 50% in water under occlusion at night 2
- Prevent recurrence: Use soap-free cleansers, regular moisturizers, and avoid known irritants 2, 1
- Occupational factors: Consider workplace modifications and protective measures for occupational CHE 5
Treatment Challenges
- Up to 65% of CHE cases do not resolve completely with standard treatments 6
- Moderate-to-severe cases often require systemic options 6
- Recent studies show that 62.9% of moderate-to-severe CHE patients receive systemic therapy 7
- Many treatments have limited evidence specifically for CHE 7
By following this structured approach to treatment, most patients with moderate to severe chronic hand eczema can achieve significant improvement in symptoms and quality of life.